Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 175,587 | 105,293 | 81,395 | 90,326 | 103,996 |
| Receivables | 337,593 | 320,320 | 299,983 | 269,312 | 268,319 |
| Inventories | 217,597 | 229,377 | 211,644 | 195,019 | 204,893 |
| Other current assets | 137,902 | 124,622 | 128,329 | 124,982 | 126,174 |
| TOTAL | $868,679 | $779,612 | $721,351 | $679,639 | $703,382 |
| Non-Current Assets | |||||
| PPE Net | 547,624 | 550,895 | 546,158 | 533,845 | 496,584 |
| Intangibles | 291,567 | 291,045 | 291,159 | 298,192 | 247,833 |
| Other Non-Current Assets | 339,537 | 339,161 | 327,577 | 320,799 | 303,682 |
| TOTAL | $1,178,728 | $1,181,101 | $1,164,894 | $1,152,836 | $1,048,099 |
| Total Assets | $2,047,407 | $1,960,713 | $1,886,245 | $1,832,475 | $1,751,481 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 49,983 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 71,933 | 73,903 | 74,210 | 72,172 | 75,515 |
| Accrued Expenses | 362,326 | 308,768 | 247,179 | 322,938 | 278,626 |
| TOTAL | $526,841 | $540,584 | $846,241 | $725,337 | $626,627 |
| Non-Current Liabilities | |||||
| Long Term Debt | 853,316 | 899,562 | 697,363 | 698,910 | 696,634 |
| Deferred Revenues | 42,599 | 36,317 | 38,028 | 41,462 | 42,986 |
| Other Non-Current Liabilities | 150,217 | 152,748 | 146,607 | 148,588 | 143,418 |
| TOTAL | $1,079,451 | $1,146,729 | $931,949 | $929,313 | $922,132 |
| Total Liabilities | $1,606,292 | $1,687,313 | $1,778,190 | $1,654,650 | $1,548,759 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,300 | 85,055 | 84,933 | 85,330 | 85,783 |
| Common Shares | 10,628 | 10,603 | 10,591 | 10,571 | 10,559 |
| Retained earnings | 2,000,805 | 1,854,586 | 1,705,646 | 1,595,648 | 1,505,152 |
| Other shareholders' equity | -56,387 | -51,245 | -50,667 | -40,911 | -40,543 |
| TOTAL | $441,115 | $273,400 | $108,055 | $177,825 | $202,722 |
| Total Liabilities And Equity | $2,047,407 | $1,960,713 | $1,886,245 | $1,832,475 | $1,751,481 |